WEST PHARM.SVCS DL-,25/ US9553061055 /
2024-09-27 3:36:43 PM | Chg. +0.60 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
275.00EUR | +0.22% | 2 Turnover: 550 |
277.80Bid Size: 36 | 279.50Ask Size: 35 | 20.18 bill.EUR | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 7.98 USD | 1.40% |
EPS Diluted: | 7.88 USD | 1.94% |
Revenues per Share: | 40.24 USD | 3.34% |
Book Value per Share: | 39.30 USD | 8.53% |
Cash Flow per Share: | 10.59 USD | 8.48% |
Dividend per Share: | 0.78 USD | 5.41% |
Total | in mill. | |
Revenues: | 2,949.80 USD | 2.18% |
Net Income: | 593.40 USD | 1.28% |
Operating Cash Flow: | 776.50 USD | - |
Cash and Cash Equivalents: | 853.90 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 38.97 | 44.13 |
P/S Ratio: | 7.73 | 8.75 |
P/BV ratio: | 7.91 | 8.96 |
P/CF Ratio: | 29.36 | 33.24 |
PEG: | 27.88 | 31.57 |
Earnings Yield: | 2.57% | 2.27% |
Dividend Yield: | 0.25% | 0.22% |
Market Capitalization | ||
Market Capitalization: | 20.18 bill. EUR | 23.38 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 72.54 mill. |
Profitability
Gross Profit Margin: | 38.28% |
EBIT Margin: | 22.92% |
Net Profit Margin: | 20.12% |
Return on Equity: | 20.60% |
Return on Assets: | 15.50% |
Financial Strength
Liquidity I / Cash Ratio: | 1.27% |
Liquidity II / Quick Ratio: | 2.03% |
Liquidity III / Current Ratio: | 2.88% |
Debt / Equity Ratio: | 0.07% |
Dynam. Debt / Equity Ratio: | 122.15% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | US GAAP |
Currency: | USD |